David A. Siegel Nls Pharmaceutics Ltd. Put Options Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NLSP
# of Institutions
9Shares Held
8.16MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA5.75MShares$1.15 Million0.03% of portfolio
-
Armistice Capital, LLC New York, NY2.17MShares$434,4000.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny180KShares$35,9150.0% of portfolio
-
Xtx Topco LTD London, X025.6KShares$5,1180.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il19.2KShares$3,8360.0% of portfolio
About NLS Pharmaceutics Ltd.
- Ticker NLSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,349,900
- Market Cap $5.87M
- Description
- NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...